Eton Pharmaceuticals Inc. News

Latest updates and market news for ETON

2 news

Feb 27 - Mar 5, 2026

Page 1

MT Newswires

3 days ago

Eton Pharmaceuticals Acquires US Commercialization Rights to Pierre Fabre's Hemangeol

📈

AI Sentiment

Highly Positive

8/10

Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution

GlobeNewswire

3 days ago

Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution

Share this news page

Share on Social Networks: